Skip to content

LBRX LBRX Interest Income

Interest Income at other companies

Alkermes logo
AlkermesALKS
$8.54M-15.8%
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
$2.47M+205%
Alto Neuroscience logo
Alto NeuroscienceANRO
$1.56M-14.6%
Opko Health logo
Opko HealthOPK
$3.01M-35.8%
Septerna, Inc. logo
Septerna, Inc.SEPN
$5.03M+12.8%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$4.36M+43.1%

Other financials

Income statement

See full
Net income-$19.1M-259%
EPS (diluted)-$0.67+95.5%

Balance sheet

See full
Cash & equivalents$320.7M
Total debt$3.5M
Total equity$378.7M+481%
Total assets$393.5M

Cash flow

See full
Operating cash flow-$23.3M-187%
CapEx$32.0K+52.4%
Free cash flow-$23.3M-186%

Valuation

See full
Market cap$874.06M+159%
Enterprise value$556.86M

Returns & leverage

See full
Return on equity-27.9%
Debt / equity
Current ratio35.7×

Where this comes from

Reported directly by LBRX in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LBRX's interest income?
LBRX (LBRX) reported interest income of $2.85M in Q1 2026.
How has LBRX's interest income changed year-over-year?
LBRX's interest income increased by 1107.6% year-over-year, from $236K to $2.85M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.